Prevalence of menopausal hormone therapy usage in symptomatic postmenopausal women in Australia

This is the authors' abstract. We don't add key points for this paper.

OBJECTIVE: This study aimed to report the prevalence of menopausal hormone therapy (MHT) usage in symptomatic postmenopausal women in Australia. METHOD: The Australian Midlife Years Study is a nationally representative, cross-sectional questionnaire-based study of women aged 40-69 years that included current MHT usage and menopausal symptoms. Data were collected during October 2023-March 2024. CONCLUSIONS: Fewer than one-quarter of symptomatic postmenopausal Australian women were using MHT, with socio-demographic variables predicting use. The overall use remains similar to that reported a decade ago.